Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Vera Therapeutics Q2 EPS $(0.55) Down From $(0.33) YoY

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.55) per share. This is a 66.67 percent decrease over losses of $(0.33) per share from the same period last year.
byBenzinga Newsdesk
August 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.55) per share. This is a 66.67 percent decrease over losses of $(0.33) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: Fisker Q2 Earnings

By Benzinga Insights
August 3, 6:36 PM
Fisker (NYSE:FSR) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings Fisker beat estimated earnings by 12.2%, reporting an EPS of $-0.36 versus an estimate of $-0.41.

FSR